Chemistry:Pinatuzumab vedotin
From HandWiki
Short description: Monoclonal antibody
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Humanized (from mouse) |
| Target | CD22 |
| Clinical data | |
| Other names | DCDT2980S, FCU2703 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C6748H10377N1773O2083S44 |
| Molar mass | 151081.21 g·mol−1 |
Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]
This drug was developed by Genentech/Roche.[citation needed]
References
- ↑ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108". WHO Drug Information 26 (4). https://www.who.int/medicines/publications/druginformation/innlists/PL108.pdf.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin, American Medical Association.
